Results 1 to 10 of about 29,428 (269)

Occupational therapy predicts post-operative left ventricular assist device (LVAD) self-care, hospital length of stay, and discharge disposition [PDF]

JHLT Open
Purpose: Understanding LVAD self-care needs is important for candidacy decisions and care planning. This study investigated the association between pre-operative occupational therapy (OT) evaluations and post-operative LVAD self-care, length of stay (LoS)
Jessica D. Asiello, OT, OTD, OTR, Kellie Cannone, OT, OTD, OTR, Nicole Lam, OT, OTD, OTR, Alyssa Taubert, OT, OTD, OTR, Marissa Dittrich, OT, MS, OTR, Shweta Gore, PhD, DPT, GCS, CLT, Erin Coglianese, MD, Christina M. Kelley, OT, MOT, OTR, CKTP   +7 more
doaj   +2 more sources

Long-term left ventricular assist device support reinforces detrimental immunological effects [PDF]

Frontiers in Immunology
IntroductionInfection is a common complication following left ventricular assist device (LVAD) implantation that increases the mortality in the post-implantation period. Immunological changes affecting dendritic cells (DCs), natural killer (NK) cells and
Maja-Theresa Dieterlen, Malina Sauskat, Kristin Klaeske, Eva Katharina Messer, Joanna Jozwiak-Nozdrzykowska, Alexey Dashkevich, Michael A. Borger, Sandra Eifert, Michal Nozdrzykowski   +8 more
doaj   +2 more sources

Recent change in bridging strategy and improved clinical outcomes following durable left ventricular assist device implantation in Japan [PDF]

JHLT Open
Background: Destination therapy (DT) was approved in Japan in May 2021. Use of Impella device as a bridge to left ventricular assist device (LVAD) implantation has been increasing.
Makiko Nakamura, Teruhiko Imamura, Yoshikatsu Saiki, Minoru Ono, Koichiro Kinugawa   +4 more
doaj   +2 more sources

Impact of mechanical circulatory support on donor heart allocation: past, present, and future [PDF]

Reviews in Cardiovascular Medicine, 2021
The United Network for Organ Sharing (UNOS) recently revised its heart allocation policy to address numerous shortcomings of the previous system. Implemented in 2018, the changes sought to reduce waiting list mortality, clearly define urgency status ...
Robert T. Tatum, H. Todd Massey, Vakhtang Tchantchaleishvili   +2 more
doaj   +1 more source

Left Ventricular Assist Device Implantation in a Patient with Ventricular Pseudoaneurysm

The Thoracic & Cardiovascular Surgeon Reports, 2022
Background Left ventricular assist device (LVAD) implantation after contained LV rupture (pseudoaneurysm) represents a difficult surgical problem. Case Description We describe the surgical approach for such a patient.
Dejan Radakovic, Kiril Penov, Gülmisal Güder, Ivan Aleksic   +3 more
doaj   +1 more source

Total Mechanical Unloading Minimizes Metabolic Demand of Left Ventricle and Dramatically Reduces Infarct Size in Myocardial Infarction. [PDF]

PLoS ONE, 2016
Left ventricular assist device (LVAD) mechanically unloads the left ventricle (LV). Theoretical analysis indicates that partial LVAD support (p-LVAD), where LV remains ejecting, reduces LV preload while increases afterload resulting from the elevation of
Keita Saku, Takamori Kakino, Takahiro Arimura, Takafumi Sakamoto, Takuya Nishikawa, Kazuo Sakamoto, Masataka Ikeda, Takuya Kishi, Tomomi Ide, Kenji Sunagawa   +9 more
doaj   +1 more source

Renal Dysfunction in Patients with Left Ventricular Assist Device

Methodist DeBakey Cardiovascular Journal, 2022
Late-stage heart failure and renal dysfunction are often seen in conjunction. Cardiorenal syndrome (CRS) describes the complex interaction between the two disease states.
Lamees I. El Nihum, Nina Manian, Priya Arunachalam, Qasim Al Abri, Ashrith Guha   +4 more
doaj   +1 more source

Aortic valve disorders and left ventricular assist devices

Frontiers in Cardiovascular Medicine, 2023
Aortic valve disorders are important considerations in advanced heart failure patients being evaluated for left ventricular assist devices (LVAD) and those on LVAD support. Aortic insufficiency (AI) can be present prior to LVAD implantation or develop de
Deepak Acharya, Toshinobu Kazui, Dina Al Rameni, Tushar Acharya, Edward Betterton, Elizabeth Juneman, Renzo Loyaga-Rendon, Kapildeo Lotun, Ranjith Shetty, Arka Chatterjee   +9 more
doaj   +1 more source

Platelet activation and aggregation in different centrifugal-flow left ventricular assist devices

Platelets, 2022
Left-ventricular assist devices (LVADs) improve outcomes in end-stage heart failure patients. Two centrifugal-flow LVAD systems are currently approved, HeartMate 3 (HM3) and Medtronic/Heartware HVAD (HVAD).
Maximilian Tscharre, Franziska Wittmann, Daniela Kitzmantl, Silvia Lee, Beate Eichelberger, Patricia P. Wadowski, Günther Laufer, Dominik Wiedemann, Birgit Forstner-Bergauer, Cihan Ay, Simon Panzer, Daniel Zimpfer, Thomas Gremmel   +12 more
doaj   +1 more source

The Interaction of Amiodarone and Continuous-flow Left Ventricular Assist Device Use in Risk of Severe Primary Graft Dysfunction Following Heart Transplantation

Transplantation Direct, 2022
Background. Primary graft dysfunction (PGD) increases morbidity and mortality after heart transplant. Here we investigated (1) the association of continuous-flow left ventricular assist device (CF-LVAD), amiodarone, and severe PGD and (2) the safety of ...
Thiru Chinnadurai, MD, Snehal R. Patel, MD, Omar Saeed, MD, Waqas Hanif, MD, Mercedes Rivas-Lasarte, MD, PhD, Muhammad Farooq, MD, Carolyne Castillo, BSN, RN, Maria Taveras, BSN, RN, Daphenie Fauvel, FNP-BC, Jooyoung J. Shin, MD, Daniel Sims, MD, Sandhya Murthy, MD, Sasha Vukelic, MD, PhD, Patricia Chavez, MD, Stephen Forest, MD, Daniel Goldstein, MD, Ulrich P. Jorde, MD   +16 more
doaj   +1 more source